THIS IS A NOTICE OF INTENT TO AWARD A SOLE-SOURCE CONTRACT AND IS NOT A REQUEST FOR COMPETITIVE PROPOSALS.

The U.S. Army Medical Research Acquisition Activity (USAMRAA), Fort Detrick, MD 21702, in support of the Center for Military Infectious Diseases Research (CIDR), Biologics Research and Development (BRaD) at  Walter Reed Army Institute of Research (WRAIR), intends to award a sole source Indefinite Delivery Indefinite Quantity (IDIQ), to Meso Scale Diagnostics, LLC, 1601 Research Blvd, Rockville, MD 20850-3126, in accordance with FAR 13.501(a)(1)(i), as the only responsible source capable of providing proprietary Multiplex consumable Assy Plates/kits and equipment compatible with Meso Scale Discovery Sector Imager 2400 and QuickPlex 120 SQ instruments.  Provisions and clauses in effect through Federal Acquisition Circular 2023-02 are incorporated.

Items included in this procurement are:

V-PLEX - COVID-19 Coronavirus Panel 1 (IgG) kit; 5 plates

K15362U-2

U-PLEX Cytokine Combo 1 (hu) Kit; 1 plate

K15045K-1

U-PLEX Cytokine Combo 1 (hu) Kit; 5 plates

K15045K-2

U-PLEX Chemokine Combo 1 (human); 1 plates

K15047K-1

U-PLEX Chemokine Combo 1 (human); 5 plates

K15047K-2

U-PLEX Proinflammatory Combo 1 (NHP) SECTOR; 1 plate

K15070K-1

U-PLEX Proinflammatory Combo 1 (NHP) SECTOR; 5 plates

K15070K-2

U-PLEX TH17 Combo 2 (human); 1 plate

K15076K-1

U-PLEX TH17 Combo 2 (human); 5 plates

K15076K-2

U-PLEX TH1/TH2 Combo (human); 1 plate

K15010K-1

U-PLEX TH1/TH2 Combo (human); 5 plates

K15010K-2

U-PLEX T-Cell Combo Human; 1 plate

K15093K-1

U-PLEX T-Cell Combo Human; 5 plates

K15093K-2

U-PLEX Viral Combo 1 Human; 1 plate

K15343K-1

U-PLEX Viral Combo 1 Human; 5 plates

K15343K-2

U-PLEX Macrophage M1 Combo 1 Human; 1 plate

K15336K-1

U-PLEX Macrophage M1 Combo 1 Human; 5 plates

K15336K-2

U-PLEX Macrophage M2 Combo 1 Human; 1 plate

K15337K-1

U-PLEX Macrophage M2 Combo 1 Human; 5 plates

K15337K-2

U-PLEX Development Pack, 10-Assay; 5 plates

K15235N-2

U-PLEX Development Pack, 10-Assay; 25 plates

K15235N-4

ELISA Conversion Pack I (uncoated plates); 20 plates

K15A01-1

V-PLEX PLUS Biomarker 54-Plex kit, Human; 1 plate

K15248G-1

V-PLEX PLUS Biomarker 54-Plex kit, Human; 5 plates

K15248G-2

V-PLEX PLUS Proinflammatory Panel 1, Human kit; 1 plate

K15049G-1

V-PLEX PLUS Proinflammatory Panel 1, Human kit; 5 plates

K15049G-2

V-PLEX PLUS Chemokine Panel 1, Human kit; 1 plate

K15047G-1

V-PLEX PLUS Chemokine Panel 1, Human kit; 5 plates

K15047G-2

V-PLEX PLUS Cytokine Panel 1, Human kit; 1 plate

K15050G-2

V-PLEX PLUS Cytokine Panel 1, Human kit; 5 plates

K15050G-2

V-PLEX PLUS TH17 Panel 1, Human kit; 1 plate

K15085G-2

V-PLEX PLUS TH17 Panel 1, Human kit; 5 plates

K15085G-2

Human/NHP IgA Detection Antibody Product; 100ug

D20JJ-6

Human/NHP IgG Detection Antibody Product; 100ug

D20JL-6

Human/NHP IgM Detection Antibody Product; 100ug

D20JP-6

SULFO-TAG Anti-Human/NHP Lambda Dection Antibody Product; 100ug

D20QG-6

SULFO-TAB Anti-Human/NHP Kappa Detection Antibody Product; 100ug

D20TF-6

MSD GOLD Sulfo-TAG NHS-Ester Conjugation (5 reactions)

R31AA-2

MSD GOLD SULFO-TAG NHS-Ester 2 micro mol

R91AO-2

Anti Rabbit Antibody Goat SULFO-TAG Labeled; 200ug

R32AB-1

Anti Rabbit Antibody Goat SULFO-TAG Labeled; 50ug

R32AB-5

Anti Mouse Antibody Goat SULFO-TAG Labeled; 200ug

R32AC-1

Anti Mouse Antibody Goat SULFO-TAG Labeled; 50ug

R32AC-5

Streptavidin SULFO-TAG Labeled; 200ug

R32AD-1

Streptavidin SULFO-TAG Labeled; 50ug

R32AD-5

Anti Human Antibody (Goat) Sulfo-TAG Labeled; 200ug

R32AJ-1

Anti Human Antibody (Goat) Sulfo-TAG Labeled; 50ug

R32AJ-5

Diluent 100; 1000mL

R50AA-3

Diluent 43; 50mL

R50AG-2

Diluent 41; 50mL

R50AH-2

Diluent 45; 40mL

R50AI-4

Diluent 40; 25mL

R50AJ-2

Diluent 42; 50mL

R50AK-2

Diluent 3, 40mL

R50AP-2

Diluent 2; 200mL

R51BB-2

Wash Buffer (20x), 100mL

R61AA-1

MSD GOLD Read Buffer A, 1000mL

R92TG-2

MSD GOLD Read Buffer B; 1000mL

R60AM-4

Read Buffer T 4x; 1000mL

R92TC-1

Read Buffer T, Surfactant Free 4x; 1000mL

R92TD-1

MESO QuickPlex SQ120MM Reader

AI1AA-0

The intended acquisition will be classified under North American Industry Classification System (NAICS) 325413, In-Vitro Diagnostics Substance Manufacturing, with a size code of 1,250 employees.

This announcement fulfills the synopsis requirements under FAR 5.102(a)(3) and 5.203(a)(1). USAMRAA intends to release a solicitation no sooner than fifteen (15) days after publishing this synopsis. This Special Notice of Intent (NOI) to Sole Source is not a request for competitive quotes. Meaningful submissions received in response to this notice will be considered solely for the purpose of determining whether a competitive procurement is in the best interest of the Government. If no meaningful, written submissions are received by the date listed below, which reflects at least fifteen (15) days after the publication of this notice, the solicitation will be issued as a sole source requirement to Meso Scale Diagnostics, LLC.

All responses concerning this notice shall be emailed to Rebecca Wisner at [email protected].  Interested concerns must identify their capability in writing to the above e-mail address no later than 10:00 AM Eastern Daylight Time (EDT), 31 May 2023. No phone calls accepted.